62
Growth Score
pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
981776
Abiel is a biotechnology company that provides R&D, production, and marketing of lytic enzymes for tissue dissociation in cell therapy.
- Giulio Ghersi: Co-Founder and CEO
- Monica Salamone: Co-founder and R&D Manager
About the Company
Abiel is an industrial and biomedical application of lytic enzymes. They specialized in the research and in the production of lytic enzymes for cell therapy and regenerative medicine. Abiel's objectives are the study, research, development, production, and commercialization of biotechnology products with particular attention to lytic enzymes
obtained by synthesis or extraction procedures to be used for cell therapy and regenerative medicine.
